The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autologous Immune Cell Storage Market Research Report 2024
Synopsis
The global Autologous Immune Cell Storage market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Autologous Immune Cell Storage is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autologous Immune Cell Storage is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Autologous Immune Cell Storage in Treat Leukemia and Blood-Related Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Autologous Immune Cell Storage include HealthBanks, Aeterna Health, Cell Vault, Redermis, Innovita Research, STEMCELL, Enhance Biomedical, Immunaeon and Miracell, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autologous Immune Cell Storage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Immune Cell Storage.
Report Scope
The Autologous Immune Cell Storage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autologous Immune Cell Storage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Immune Cell Storage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
VCANBIO Cell and Gene Engineering Corp., Ltd.
Shenzhen Beike Bio-Technology Co.,Ltd
Beijing Health and Biotech Group Corp. Ltd.
Shanghai Cell Therapy Group Co. Ltd.
BGI Genomics
Shanghai Saiyao Biotechnology Co., Ltd.
Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
Segment by Type
Lymphocyte Storage
Hematopoietic Stem Cell Storage
Segment by Application
Treat Leukemia and Blood-Related Diseases
Immune System Modulation
Stem Cell Transplant
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous Immune Cell Storage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Autologous Immune Cell Storage market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Autologous Immune Cell Storage is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autologous Immune Cell Storage is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Autologous Immune Cell Storage in Treat Leukemia and Blood-Related Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Autologous Immune Cell Storage include HealthBanks, Aeterna Health, Cell Vault, Redermis, Innovita Research, STEMCELL, Enhance Biomedical, Immunaeon and Miracell, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autologous Immune Cell Storage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Immune Cell Storage.
Report Scope
The Autologous Immune Cell Storage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autologous Immune Cell Storage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Immune Cell Storage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
VCANBIO Cell and Gene Engineering Corp., Ltd.
Shenzhen Beike Bio-Technology Co.,Ltd
Beijing Health and Biotech Group Corp. Ltd.
Shanghai Cell Therapy Group Co. Ltd.
BGI Genomics
Shanghai Saiyao Biotechnology Co., Ltd.
Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
Segment by Type
Lymphocyte Storage
Hematopoietic Stem Cell Storage
Segment by Application
Treat Leukemia and Blood-Related Diseases
Immune System Modulation
Stem Cell Transplant
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous Immune Cell Storage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Immune Cell Storage Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lymphocyte Storage
1.2.3 Hematopoietic Stem Cell Storage
1.3 Market by Application
1.3.1 Global Autologous Immune Cell Storage Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Treat Leukemia and Blood-Related Diseases
1.3.3 Immune System Modulation
1.3.4 Stem Cell Transplant
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous Immune Cell Storage Market Perspective (2019-2030)
2.2 Autologous Immune Cell Storage Growth Trends by Region
2.2.1 Global Autologous Immune Cell Storage Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autologous Immune Cell Storage Historic Market Size by Region (2019-2024)
2.2.3 Autologous Immune Cell Storage Forecasted Market Size by Region (2025-2030)
2.3 Autologous Immune Cell Storage Market Dynamics
2.3.1 Autologous Immune Cell Storage Industry Trends
2.3.2 Autologous Immune Cell Storage Market Drivers
2.3.3 Autologous Immune Cell Storage Market Challenges
2.3.4 Autologous Immune Cell Storage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Immune Cell Storage Players by Revenue
3.1.1 Global Top Autologous Immune Cell Storage Players by Revenue (2019-2024)
3.1.2 Global Autologous Immune Cell Storage Revenue Market Share by Players (2019-2024)
3.2 Global Autologous Immune Cell Storage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autologous Immune Cell Storage Revenue
3.4 Global Autologous Immune Cell Storage Market Concentration Ratio
3.4.1 Global Autologous Immune Cell Storage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Immune Cell Storage Revenue in 2023
3.5 Autologous Immune Cell Storage Key Players Head office and Area Served
3.6 Key Players Autologous Immune Cell Storage Product Solution and Service
3.7 Date of Enter into Autologous Immune Cell Storage Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Immune Cell Storage Breakdown Data by Type
4.1 Global Autologous Immune Cell Storage Historic Market Size by Type (2019-2024)
4.2 Global Autologous Immune Cell Storage Forecasted Market Size by Type (2025-2030)
5 Autologous Immune Cell Storage Breakdown Data by Application
5.1 Global Autologous Immune Cell Storage Historic Market Size by Application (2019-2024)
5.2 Global Autologous Immune Cell Storage Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autologous Immune Cell Storage Market Size (2019-2030)
6.2 North America Autologous Immune Cell Storage Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autologous Immune Cell Storage Market Size by Country (2019-2024)
6.4 North America Autologous Immune Cell Storage Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous Immune Cell Storage Market Size (2019-2030)
7.2 Europe Autologous Immune Cell Storage Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autologous Immune Cell Storage Market Size by Country (2019-2024)
7.4 Europe Autologous Immune Cell Storage Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous Immune Cell Storage Market Size (2019-2030)
8.2 Asia-Pacific Autologous Immune Cell Storage Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autologous Immune Cell Storage Market Size by Region (2019-2024)
8.4 Asia-Pacific Autologous Immune Cell Storage Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous Immune Cell Storage Market Size (2019-2030)
9.2 Latin America Autologous Immune Cell Storage Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autologous Immune Cell Storage Market Size by Country (2019-2024)
9.4 Latin America Autologous Immune Cell Storage Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Immune Cell Storage Market Size (2019-2030)
10.2 Middle East & Africa Autologous Immune Cell Storage Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2019-2024)
10.4 Middle East & Africa Autologous Immune Cell Storage Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HealthBanks
11.1.1 HealthBanks Company Detail
11.1.2 HealthBanks Business Overview
11.1.3 HealthBanks Autologous Immune Cell Storage Introduction
11.1.4 HealthBanks Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.1.5 HealthBanks Recent Development
11.2 Aeterna Health
11.2.1 Aeterna Health Company Detail
11.2.2 Aeterna Health Business Overview
11.2.3 Aeterna Health Autologous Immune Cell Storage Introduction
11.2.4 Aeterna Health Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.2.5 Aeterna Health Recent Development
11.3 Cell Vault
11.3.1 Cell Vault Company Detail
11.3.2 Cell Vault Business Overview
11.3.3 Cell Vault Autologous Immune Cell Storage Introduction
11.3.4 Cell Vault Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.3.5 Cell Vault Recent Development
11.4 Redermis
11.4.1 Redermis Company Detail
11.4.2 Redermis Business Overview
11.4.3 Redermis Autologous Immune Cell Storage Introduction
11.4.4 Redermis Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.4.5 Redermis Recent Development
11.5 Innovita Research
11.5.1 Innovita Research Company Detail
11.5.2 Innovita Research Business Overview
11.5.3 Innovita Research Autologous Immune Cell Storage Introduction
11.5.4 Innovita Research Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.5.5 Innovita Research Recent Development
11.6 STEMCELL
11.6.1 STEMCELL Company Detail
11.6.2 STEMCELL Business Overview
11.6.3 STEMCELL Autologous Immune Cell Storage Introduction
11.6.4 STEMCELL Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.6.5 STEMCELL Recent Development
11.7 Enhance Biomedical
11.7.1 Enhance Biomedical Company Detail
11.7.2 Enhance Biomedical Business Overview
11.7.3 Enhance Biomedical Autologous Immune Cell Storage Introduction
11.7.4 Enhance Biomedical Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.7.5 Enhance Biomedical Recent Development
11.8 Immunaeon
11.8.1 Immunaeon Company Detail
11.8.2 Immunaeon Business Overview
11.8.3 Immunaeon Autologous Immune Cell Storage Introduction
11.8.4 Immunaeon Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.8.5 Immunaeon Recent Development
11.9 Miracell
11.9.1 Miracell Company Detail
11.9.2 Miracell Business Overview
11.9.3 Miracell Autologous Immune Cell Storage Introduction
11.9.4 Miracell Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.9.5 Miracell Recent Development
11.10 VCANBIO Cell and Gene Engineering Corp., Ltd.
11.10.1 VCANBIO Cell and Gene Engineering Corp., Ltd. Company Detail
11.10.2 VCANBIO Cell and Gene Engineering Corp., Ltd. Business Overview
11.10.3 VCANBIO Cell and Gene Engineering Corp., Ltd. Autologous Immune Cell Storage Introduction
11.10.4 VCANBIO Cell and Gene Engineering Corp., Ltd. Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.10.5 VCANBIO Cell and Gene Engineering Corp., Ltd. Recent Development
11.11 Shenzhen Beike Bio-Technology Co.,Ltd
11.11.1 Shenzhen Beike Bio-Technology Co.,Ltd Company Detail
11.11.2 Shenzhen Beike Bio-Technology Co.,Ltd Business Overview
11.11.3 Shenzhen Beike Bio-Technology Co.,Ltd Autologous Immune Cell Storage Introduction
11.11.4 Shenzhen Beike Bio-Technology Co.,Ltd Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.11.5 Shenzhen Beike Bio-Technology Co.,Ltd Recent Development
11.12 Beijing Health and Biotech Group Corp. Ltd.
11.12.1 Beijing Health and Biotech Group Corp. Ltd. Company Detail
11.12.2 Beijing Health and Biotech Group Corp. Ltd. Business Overview
11.12.3 Beijing Health and Biotech Group Corp. Ltd. Autologous Immune Cell Storage Introduction
11.12.4 Beijing Health and Biotech Group Corp. Ltd. Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.12.5 Beijing Health and Biotech Group Corp. Ltd. Recent Development
11.13 Shanghai Cell Therapy Group Co. Ltd.
11.13.1 Shanghai Cell Therapy Group Co. Ltd. Company Detail
11.13.2 Shanghai Cell Therapy Group Co. Ltd. Business Overview
11.13.3 Shanghai Cell Therapy Group Co. Ltd. Autologous Immune Cell Storage Introduction
11.13.4 Shanghai Cell Therapy Group Co. Ltd. Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.13.5 Shanghai Cell Therapy Group Co. Ltd. Recent Development
11.14 BGI Genomics
11.14.1 BGI Genomics Company Detail
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics Autologous Immune Cell Storage Introduction
11.14.4 BGI Genomics Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.14.5 BGI Genomics Recent Development
11.15 Shanghai Saiyao Biotechnology Co., Ltd.
11.15.1 Shanghai Saiyao Biotechnology Co., Ltd. Company Detail
11.15.2 Shanghai Saiyao Biotechnology Co., Ltd. Business Overview
11.15.3 Shanghai Saiyao Biotechnology Co., Ltd. Autologous Immune Cell Storage Introduction
11.15.4 Shanghai Saiyao Biotechnology Co., Ltd. Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.15.5 Shanghai Saiyao Biotechnology Co., Ltd. Recent Development
11.16 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd.
11.16.1 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Company Detail
11.16.2 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Business Overview
11.16.3 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Autologous Immune Cell Storage Introduction
11.16.4 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Revenue in Autologous Immune Cell Storage Business (2019-2024)
11.16.5 Guangzhou SALIAI Stemcell Science and Technology Co.,Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
